Improving the immune response to viruses through memory B cells
Enhancing the antiviral memory B cell response
['FUNDING_OTHER'] · WASHINGTON UNIVERSITY · NIH-11176615
This study is looking at ways to help your immune system remember and fight off quickly changing viruses, like COVID-19, by creating special cells that can recognize and attack these viruses faster, with the goal of making better vaccines for everyone.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | WASHINGTON UNIVERSITY (nih funded) |
| Locations | 1 site (SAINT LOUIS, UNITED STATES) |
| Trial ID | NIH-11176615 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the body's immune response to rapidly mutating viruses by developing memory B cells that can quickly recognize and neutralize these viruses upon re-infection. The approach involves understanding how these long-lived memory B cells can be induced and improved through exposure to viral antigens. By studying the mechanisms that govern the development and function of these cells, the research aims to create more effective vaccines that can provide broad protection against various viral infections, including those that cause pandemics like COVID-19.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who are at risk of viral infections, particularly those caused by rapidly mutating viruses.
Not a fit: Patients who are not at risk for viral infections or those who have already developed effective immunity may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to vaccines that provide long-lasting immunity against rapidly mutating viruses, improving public health outcomes.
How similar studies have performed: Other research has shown promise in enhancing memory B cell responses, indicating that this approach could lead to significant advancements in vaccine development.
Where this research is happening
SAINT LOUIS, UNITED STATES
- WASHINGTON UNIVERSITY — SAINT LOUIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LAIDLAW, BRIAN — WASHINGTON UNIVERSITY
- Study coordinator: LAIDLAW, BRIAN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.